Request a FREE Sample of our FcRn Binding Kit!Request a FREE Sample of our Fc gamma RI / CD64 Binding Kit !
Happy Holiday! Limited Keychain here with your next orderHappy Holiday! Limited Keychain here with your next order
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CDO-H52H3 | Human | Human CD45RO Protein, His Tag (MALS verified) |
|
The purity of Human CD45RO Protein, His Tag (Cat. No. CDO-H52H3) is more than 85% and the molecular weight of this protein is around 80-105 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Immunomodulatory progenitor cell therapy (Celixir) | Phase 3 Clinical | Celixir | Endomyocardial Fibrosis; Cardiomyopathies | Details | |
I-131-Apamistamab | 131IBC8; BC8-I-131; BC-8 | Phase 3 Clinical | Fred Hutchinson Cancer Research Center | Leukemia, Myeloid, Acute; Sezary Syndrome; Neoplasms, Gonadal Tissue; Waldenstrom Macroglobulinemia; Lymphoma; Burkitt Lymphoma; Lymphoma, Non-Hodgkin; Intraocular Lymphoma; Lymphoma, T-Cell; Pancytopenia; Lymphoma, T-Cell, Cutaneous; Anemia, Sideroblastic; Lymphoma, Large-Cell, Anaplastic; Leukemia, T-Cell; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Mycosis Fungoides; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Hematopoietic stem cell transplantation (HSCT); Leukemia; Neoplastic Cells, Circulating; Leukemia, Hairy Cell; Anemia, Refractory, with Excess of Blasts; Hodgkin Disease; Lymphoma, T-Cell, Peripheral; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Lymphomatoid Granulomatosis; Lymphoma, Large B-Cell, Diffuse; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Follicular; Lymphoma, Mantle-Cell | Details |
At 211 MAb BC8-B10 | Phase 2 Clinical | Fred Hutchinson Cancer Research Center | Neoplasms | Details | |
Immunomodulatory progenitor cell therapy (Celixir) | Phase 3 Clinical | Celixir | Endomyocardial Fibrosis; Cardiomyopathies | Details | |
I-131-Apamistamab | 131IBC8; BC8-I-131; BC-8 | Phase 3 Clinical | Fred Hutchinson Cancer Research Center | Leukemia, Myeloid, Acute; Sezary Syndrome; Neoplasms, Gonadal Tissue; Waldenstrom Macroglobulinemia; Lymphoma; Burkitt Lymphoma; Lymphoma, Non-Hodgkin; Intraocular Lymphoma; Lymphoma, T-Cell; Pancytopenia; Lymphoma, T-Cell, Cutaneous; Anemia, Sideroblastic; Lymphoma, Large-Cell, Anaplastic; Leukemia, T-Cell; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Mycosis Fungoides; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Hematopoietic stem cell transplantation (HSCT); Leukemia; Neoplastic Cells, Circulating; Leukemia, Hairy Cell; Anemia, Refractory, with Excess of Blasts; Hodgkin Disease; Lymphoma, T-Cell, Peripheral; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Lymphomatoid Granulomatosis; Lymphoma, Large B-Cell, Diffuse; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Follicular; Lymphoma, Mantle-Cell | Details |
At 211 MAb BC8-B10 | Phase 2 Clinical | Fred Hutchinson Cancer Research Center | Neoplasms | Details |
This web search service is supported by Google Inc.